Search

everythinglearnresearchcommunity

for

Search:↓

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Finasteride can cause sexual and psychological side effects, but these usually reverse after stopping the medication.

Fenugreek extract may help treat benign prostatic hyperplasia.

Plant-based treatments may help reduce BPH symptoms, but more research is needed.

Finasteride and dutasteride are equally effective and safe for treating BPH.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

The study's methods are flawed, making its conclusions about finasteride and mental health unreliable.

People with hair loss may have worse urinary symptoms due to an enlarged prostate.

Finasteride users have a very low risk of mental health issues, but those with hair loss may have slightly higher anxiety and depression.

Men with male pattern baldness are more likely to have benign prostatic hyperplasia.

Finasteride effectively treats BPH but requires continuous use to maintain benefits.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Certain gene variants may raise the risk of prostate enlargement, but taking NSAIDs could reduce this risk.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Adherence to finasteride treatment for prostate issues is generally low.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Finasteride for hair loss lowers PSA levels, so PSA values need adjusting when screening for prostate cancer.

Incidental prostate cancer was found in 4.89% of patients undergoing surgery for benign prostatic hyperplasia.

Serenoa repens may help with prostate issues, but more research is needed to confirm its effectiveness.

Using finasteride and doxazosina together works better for treating benign prostatic hyperplasia than using just one.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Hair loss linked to prostate enlargement; stress and family history important factors.

Different prostate cancer treatments have similar risks of secondary cancers and related mortality when considering patient age and smoking history.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.